West Pharmaceutical Services Inc introduced its latest analytical services with a testing platform to help clients mitigate the risks associated with testing pulmonary and nasal drug products and associated delivery devices.

The company's analytical services for pulmonary and nasal drug products encompass early-stage development, clinical development, and postproduct launch stages for pharmaceutical, biotechnology, and medical device clients.